Bloomage Biotechnology Corp Ltd (688363) - Total Assets
Based on the latest financial reports, Bloomage Biotechnology Corp Ltd (688363) holds total assets worth CN¥8.75 Billion CNY (≈ $1.28 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bloomage Biotechnology Corp Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Bloomage Biotechnology Corp Ltd's total assets have evolved over time, based on quarterly financial data. Also see 688363 market cap overview for the company's overall valuation and market capitalisation.
Bloomage Biotechnology Corp Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Bloomage Biotechnology Corp Ltd's total assets of CN¥8.75 Billion consist of 32.0% current assets and 68.0% non-current assets. Review total liabilities of Bloomage Biotechnology Corp Ltd to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.5% |
| Accounts Receivable | CN¥564.47 Million | 6.5% |
| Inventory | CN¥980.62 Million | 11.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥517.62 Million | 6.0% |
| Goodwill | CN¥177.62 Million | 2.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Bloomage Biotechnology Corp Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Bloomage Biotechnology Corp Ltd (688363) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bloomage Biotechnology Corp Ltd's current assets represent 32.0% of total assets in 2025, a decrease from 54.7% in 2012.
- Cash Position: Cash and equivalents constituted 11.5% of total assets in 2025, down from 25.5% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 11.3% of total assets.
Bloomage Biotechnology Corp Ltd Competitors by Total Assets
Key competitors of Bloomage Biotechnology Corp Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Grace Fabric Technology Co Ltd
SHG:603256
|
China | CN¥5.89 Billion |
|
China Minmetals Rare Earth Co Ltd
SHE:000831
|
China | CN¥5.82 Billion |
|
Zibo Qixiang Tengda Chemical Co Ltd
SHE:002408
|
China | CN¥23.70 Billion |
|
Shandong Dawn Polymer Co Ltd
SHE:002838
|
China | CN¥8.74 Billion |
|
Ningxia Xinri Hengli Steel Wire Rope Co Ltd
SHG:600165
|
China | CN¥2.34 Billion |
|
Xiamen Yanjan New Material Co Ltd
SHE:300658
|
China | CN¥2.90 Billion |
|
Guangdong Delian Group Co Ltd
SHE:002666
|
China | CN¥5.41 Billion |
|
Ningbo Color Master Batch Co. Ltd.
SHE:301019
|
China | CN¥1.20 Billion |
Bloomage Biotechnology Corp Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.36 | 2.37 | 4.05 |
| Quick Ratio | 1.59 | 1.27 | 3.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.65 Billion | CN¥1.53 Billion | CN¥2.86 Billion |
Bloomage Biotechnology Corp Ltd - Advanced Valuation Insights
This section examines the relationship between Bloomage Biotechnology Corp Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.61 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | 0.4% |
| Total Assets | CN¥8.69 Billion |
| Market Capitalization | $2.47 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Bloomage Biotechnology Corp Ltd's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bloomage Biotechnology Corp Ltd's assets grew by 0.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bloomage Biotechnology Corp Ltd (2012–2025)
The table below shows the annual total assets of Bloomage Biotechnology Corp Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥8.69 Billion ≈ $1.27 Billion |
+0.41% |
| 2024-12-31 | CN¥8.66 Billion ≈ $1.27 Billion |
+2.20% |
| 2023-12-31 | CN¥8.47 Billion ≈ $1.24 Billion |
-2.44% |
| 2022-12-31 | CN¥8.68 Billion ≈ $1.27 Billion |
+15.70% |
| 2021-12-31 | CN¥7.50 Billion ≈ $1.10 Billion |
+31.26% |
| 2020-12-31 | CN¥5.72 Billion ≈ $836.56 Million |
+14.99% |
| 2019-12-31 | CN¥4.97 Billion ≈ $727.51 Million |
+140.06% |
| 2018-12-31 | CN¥2.07 Billion ≈ $303.05 Million |
+9.98% |
| 2017-12-31 | CN¥1.88 Billion ≈ $275.55 Million |
+11.81% |
| 2016-12-31 | CN¥1.68 Billion ≈ $246.45 Million |
-23.42% |
| 2015-12-31 | CN¥2.20 Billion ≈ $321.81 Million |
+127.79% |
| 2014-12-31 | CN¥965.44 Million ≈ $141.27 Million |
+25.66% |
| 2013-12-31 | CN¥768.31 Million ≈ $112.43 Million |
+62.00% |
| 2012-12-31 | CN¥474.26 Million ≈ $69.40 Million |
-- |
About Bloomage Biotechnology Corp Ltd
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers beauty and care products under brand Hymagic-VCHA VC Hylauronic Acid; Biomeet-MarineDNA; Bioyouth-SPG Schizophyllan Gel; Hymagic-GluHA; Bloomsurfact EncapCare RP; Bloomsurfact Sodium Surfactin; Hybloom Minitrue; Bioyouth-EGT Pure Ultrapure Ergothioneine; miniHA HA-Oligo degraded by… Read more